BTAI
#4520
BioXcel Therapeutics, Inc. - Common Stock
0.8 8 USD
+0.07%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+7.32%
Monthly Change
-24.14%
6 month change
-44.30%
Year Change
-44.30%
Previous Close
0.8 2
Open
0.8 8
Low
0.8 8
High
0.8 8
Volume
10
Financials
- Market Capitalization 27.17 M
- Employee 29
- Founded 2017
- CEO N/A
- Website www.bioxceltherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00K20GVD2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.28
Price to sales ratio
25.81
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4504 |  PSTV PLUS THERAPEUTICS, Inc. - Common Stock | 4.17 USD | +4.25% | +3.73% | -18.40% | +1163.64% | 28.70 M USD | ||
| 4505 |  ATNM Actinium Pharmaceuticals, Inc. Common Stock | 0.91 USD | -3.19% | -5.21% | -10.78% | -12.50% | 28.55 M USD | ||
| 4522 |  GRDX GridAI Technologies Corp. - Common Stock | 4.07 USD | -9.56% | -6.86% | -26.00% | +59.61% | 27.08 M USD | ||
| 4529 |  IGC IGC Pharma, Inc. Common Stock | 0.26 USD | -3.70% | -7.14% | -7.14% | +1.48% | 26.02 M USD |
Frequently asked questions about BioXcel Therapeutics, Inc. - Common Stock
What is the BioXcel Therapeutics, Inc. - Common Stock stock price today?
The current price of BioXcel Therapeutics, Inc. - Common Stock (BTAI) is 0.88. Over the past 24 hours, the stock has changed by +7.32%. Follow the BTAI chart for real-time price dynamics.
What is the stock ticker of BioXcel Therapeutics, Inc. - Common Stock?
BioXcel Therapeutics, Inc. - Common Stock trades under the ticker BTAI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioXcel Therapeutics, Inc. - Common Stock stock going up?
BTAI has changed by -20.72% over the last week, -24.14% over the last month, and -44.30% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was BioXcel Therapeutics, Inc. - Common Stock net income for the last quarter?
BioXcel Therapeutics, Inc. - Common Stock reported net income of -12.69 M for the last quarter. The previous quarter showed -12.54 M, which means net income changed by -1.16%.
How many employees does BioXcel Therapeutics, Inc. - Common Stock have?
As of the latest available data, BioXcel Therapeutics, Inc. - Common Stock has 29 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioXcel Therapeutics, Inc. - Common Stock EBITDA?
BioXcel Therapeutics, Inc. - Common Stock EBITDA is -9.66 M, and its EBITDA margin is -4 690.78%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioXcel Therapeutics, Inc. - Common Stock stock?
You can buy BioXcel Therapeutics, Inc. - Common Stock (BTAI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioXcel Therapeutics, Inc. - Common Stock stock?
Investing in BioXcel Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BTAI chart and related analysis on metatrader.com as part of your research.